IL6 and Alzheimer disease: In AD, brain‐resident immune cells, particularly microglia, undergo sustained activation and release proinflammatory cytokines (e.g., interleukin [IL] ‐1β, IL‐6, and TNF‐α) and reactive oxygen species.